India Adhesives Market Forecast & Opportunities , 2020

P h a r m a & H e a l t h c a r e C o n s u l t a n t s

U n i te d S t a te s H o s p i t a l - a c q u i re d I n f e c t i o n s P reve n t i o n M a r ke t O p p o r t u n i t i e s , 2 0 1 0 - 2 0 2 0

2

R e s e a r c h M e t h o d o l o g y

© Pharmaion

Primary Research

•Identifying Key Opinion Leaders

•Questionnaire Design

•In-depth Interviews

•Coverage across Value Chain market

Market Estimation & Forecasting

Bottom-Up or Top-down approach for Market size estimation

Historical trend examination

Impact analysis of drivers and challenges to market growth

Statistical evaluation to develop the actual forecast

Data Validation, Analysis and Interpretation

Data validation through Primary & Secondary outreach, data analysis and interpretation of key findings

Preliminary Data Mining

Qualitative and Quantitative research

2015E 2016F 2017F 2018F 2019F 2020F

CAGR (2015E-2020F): XX%

US Hospital-acquired Infections Prevention Market Opportunities, 2020

Secondary Research

•Government websites

•Company annual reports, white papers, investor presentations and financial reports

3

R e s e a r c h M e t h o d o l o g y

© Pharmaion

Baseline Methodology:

For the study of the United States hospital-acquired infections prevention market, Pharmaion has gathered

information through an exhaustive search of credible databases prudently evaluated all the collected information

and presented it in the most accurate and detailed manner.

Primary Sources

Key Stakeholders:

Product/Brand Managers

Business Development

Managers

Regional Mangers

Regulatory Affairs Personnel

Marketing & Sales Managers

Head of Patient Support

Programme

Substantial data points for analysis, interpretation and market size estimation

Data Triangulation

(Data validation

through cross verification

from primary & secondary

sources)

Qualitative and quantitative data from company

website, financial reports, research articles, designed

questionnaires etc.

In-depth interviews of key stakeholders of

major companies

Secondary Sources

Analysis of Data from credible sources: Centers for Disease Control

and Prevention (CDC) American Cancer Institute American Hospital Directory

Calculation of Sub- segment market size

4

R e s e a r c h M e t h o d o l o g y

© Pharmaion

United States Hospital-acquired Infections Prevention Market - Market Size Estimation

United States Hospital-acquired Infections Prevention market has been segmented into two categories:Disinfection and Sterilization

Sterilization has been further categorized into three sub-segments: Equipment, Services, andConsumables

Disinfection has been further classified into six sub segments: Disinfection Robots, Disinfectants,Endoscope Reprocessors, Disinfectors, Wipes, and Personal-use Non-wovens.

Calculation of United States Sterilization for

Hospital-acquired Infections Prevention

Market Size

To

p-d

ow

n A

pp

ro

ach B

otto

m-u

p A

pp

ro

ach

Calculation of Sub-

segment market size

Calculation of United

States Disinfection for Hospital-

acquired Infections Prevention Market Size

Total Market Size = Sterilization Market Size + Disinfection

Market Size

Regional & Company Market Size =

Respective Market Share (from primary

and secondary research) X Total

Market Value

5

T a b l e o f C o n t e n t s

© Pharmaion

S No. Contents

1. Hospital-acquired Infections Prevention Overview

2. Research Methodology

3. Analyst View

4. Global Hospital-acquired Infections Prevention Market Overview

5. United States Hospital-acquired Infections Prevention Market Outlook

5.1. Market Size and Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Prevention Type

5.2.2. By Region

5.2.3. By Company

6. United States Sterilization for Hospital-acquired Infections Prevention Market Outlook

6.1. Market Size and Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type

7. United States Disinfection for Hospital-acquired Infections Prevention Market Outlook

7.1. Market Size and Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type

6

T a b l e o f C o n t e n t s

© Pharmaion

S No. Contents

8. Market Dynamics

8.1. Drivers

8.2. Challenges

9. Market Trends & Developments

9.1. UV Disinfecting Robots – Future of Disinfection

9.2. Plummeting Surgical Site Infections

9.3. RFID – Technology for Monitoring Hand Hygiene

9.4. Gas Plasma Sterilization Technology

9.5. Hospital Infection Prevention from Digital Technology

10. Regulatory Framework and Guidelines

10.1. Deficit Reduction Act of 2005

10.2. Guidelines

11. United States Economic Profile

12. Competitive Landscape

12.1. Competition Benchmarking

12.2. Company Profiles

12.2.1. Steris Corporation

12.2.2. Advanced Sterilization Products

12.2.3. Getinge USA, Inc.

12.2.4. 3M Company

12.2.5. Belimed

12.2.6. Cantel Medical Corp.

7

T a b l e o f C o n t e n t s

© Pharmaion

S No. Contents

12.2.7. Halyard Health, Inc.

12.2.8. Cisa America Inc.

12.2.9. Cardinal Health, Inc.

12.2.10. Tuttnauer USA Co. Ltd.

13. Strategic Recommendations

14. About Us & Disclaimer

I n d u s t r y B r i e f

8

© Pharmaion

United States Hospital-acquired Infections Prevention Market to Grow at Over 7% Until 2020

Growing incidence of hospital-acquired infections and stringent government policies to drive the United Stateshospital-acquired infections prevention market through 2020

According to recently published Pharmaion report,“United States Hospital-acquired Infections Prevention MarketOpportunities, 2010 - 2020”, hospital-acquired infections prevention market in the United States is projected togrow at a CAGR of over 7% during 2015 - 2020. Growth in the US hospital-acquired infections prevention marketcan be attributed to growing incidence of hospital-acquired infections and rising prevalence of chronic diseasesamong geriatric population. Moreover, implementation of stringent laws against hospitals with regards to hospital-acquired infections, under the Deficit Regulation Act, 2005,is also anticipated to drive demand for hospital-acquired infections prevention market in the United States during 2015 - 2020.

On the basis of prevention type, the market has been segmented into two categories, namely, sterilization anddisinfection. Among these categories, sterilization segment dominated the United States hospital-acquiredinfections prevention market in 2014, and is anticipated to continue its dominance during forecast period onaccount of its high efficiency and capability to clean and kill microorganisms in extreme corners of medical devicesused in diagnostic and treatment procedures. South region accounted for the largest share in the United Stateshospital-acquired infections prevention market in 2014, followed by the Midwest, West and North-East regions.

“With increasing adoption of UV disinfecting robots and RFID, a technology for monitoring hand hygiene, coupledwith growing adoption of gas plasma sterilization technology, the market for hospital-acquired infectionsprevention market in the United States is anticipated to grow at a robust pace over the next five years. Moreover,Office of Disease Prevention and Health Promotion (ODPHP) and US Department of Health and Human Services(HHS) developed the “National Action Plan to Prevent Health Care-Associated Infections: Road Map toElimination” in 2009. This plan was focused to prevent hospital-acquired infections across all health care settings,including acute care hospitals, ambulatory surgical centres, end-stage renal disease facilities and long-term carefacilities.” said Mr. Karan Chechi, Research Director, with Pharmaion Consultants, a research based globalpharmaceutical and healthcare consulting firm.

9

Hospital-acquired infection, also known as nosocomial infection, is defined as an infection whose development

takes place in a favourable hospital environment, specifically those which are acquired by a patient during a

hospital visit and often develop among the hospital staff.

Hospital-acquired infections majorly leads to severe pneumonia and infections of bloodstream, urinary tract

and other parts of the body.

© Pharmaion

Hospital-acquired Infections

SSI, 20%

CAUTI, 20%

HO-HCFA CDI,

20%

CLABSI, 20%

VAP, 20%

United States Hospital-acquired Infections Share, 2013

Abbreviations Used:

XXXX

XXXX

XXXX

XXXX

XXXX

H o s p i t a l - a c q u i r e d I n f e c t i o n s P r e v e n t i o n O v e r v i e w

10

S a m p l e D a t a - S n a p s h o t

© Pharmaion

United States Hospital-acquired Infections Prevention

Market Size, By Value, 2010-2020F (USD Billion)

1 2 3 4 5 6 7 8 9 10 11

1 2 3 4 5 6 7 8 9 10

United States Number of Deaths from

10 Leading Causes, 2013

Surgical Site Infections, 20.0%

Ventilator-associated

Pneumonia, 20.0%

Central line-associated

bloodstream infection,

20.0%

C. Difficile Infections,

20.0%

Catheter-associated

UTIs, 20.0%

United States Costs of Commonly Hospital-acquired

Infections Diagnosis & Treatment, 2012 (%)

12

34

5

2010 2011 2012 2013 2014

North-East Region

12

34

5

2010 2011 2012 2013 2014

West Region

12

34

5

2010 2011 2012 2013 2014

Midwest Region

12

34

5

2010 2011 2012 2013 2014

South Region

United States Hospital-acquired Infections Prevention Market

Size, By Region, By Value, 2010-2014 (USD Million)

United States Hospital-acquired Infections Prevention Market Share, By

Company, By Value, 2010-2020F

30.1% 30.2% 30.3% 30.4% 30.5% 30.6% 30.7% 30.8% 30.9% 31% 31.1%

5% 5.1% 5.2% 5.3% 5.4% 5.5% 5.6% 5.7% 5.8% 5.9% 6%

14% 14.1% 14.2% 14.3% 14.4% 14.5% 14.6% 14.7% 14.8% 14.9% 15%

16% 16.1% 16.2% 16.3% 16.4% 16.5% 16.6% 16.7% 16.8% 16.9% 17%

31% 31.1% 31.2% 31.3% 31.4% 31.5% 31.6% 31.7% 31.8% 31.9% 32%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Others 3M Company Getinge USA Inc.

ASP Steris Corporation

11

R e p o r t O r d e r i n g

License Type Price

Single User License $2500

Single User License Print $3000

Enterprise License $5000

To View Sample OR Purchase Report

Report Price

Report Name: United States Hospital-acquired Infections Prevention

Market Opportunities, 2010-2020

© Pharmaion

12

A b o u t U s & D i s c l a i m e r

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

sales@pharmaion.com

+1 646 360 1656

www.pharmaion.com

About Us :

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customerswith high value market research and advisory services that helps them identify new market opportunities, growth engines andinnovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound bylegacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology asengines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reportsdo not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trainedindustry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consultingrequirements.

Related Reports

United States Autoimmune Disorders Diagnostics Market Opportunities, 2020

Global Tissue Engineered Medical Devices Market Opportunities, 2020

Global Cervical Cancer Vaccine Market Opportunities, 2020

Disclaimer :The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is madethat it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained fromvarious sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy orcompleteness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information andespecially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimatesand forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’sinternal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

ASIA PACIFIC

Pharmaion Consultants Pvt. Ltd.

A – 51, Sector 57, Noida, National Capital Region,

India - 201301

sales@pharmaion.com

+91 - 120 - 452 3900

www.pharmaion.com© Pharmaion